Stockreport

Cempra Withdraws Solithromycin Marketing Authorization Application in Europe

CEMPRA  (CEMP) 
US:NASDAQ Investor Relations: ir.melinta.com/investor-relations
PDF CHAPEL HILL, N.C., March 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-inf [Read more]